Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ambrish Srivastava

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of the Association of Physicians of India|May 1, 2017
Calcium and Calcium SaltsAbhijit Trailokya, Ambrish Srivastava, Milind Bhole, et al.
The Journal of the Association of Physicians of India|February 10, 2025
Real-world Evidence Simplified for CliniciansAbhijit Anil Trailokya, Ambrish Srivastava, Qayum Mukaddam, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Phase IV Studies: What Clinicians Need to Know!Abhijit Trailokya, Ambrish Srivastava, Qayum Mukaddam, et al.
Current Diabetes Reviews|September 16, 2011
Linagliptin: a novel xanthine-based dipeptidyl peptidase-4 inhibitor for treatment of type II diabetes mellitusSomsuvra B Ghatak, Devang S Patel, Neeraj Shanker, et al.
Clinical Drug Investigation|August 12, 2009
Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjectsKumar P Chandra, Ajay Shiwalkar, Jignesh Kotecha, et al.
The Journal of the Association of Physicians of India|July 18, 2019
A Multicentre, Open label, Randomized, Comparative, Parallel Group, Active-controlled, Phase III Clinical Trial to Evaluate Safety and Efficacy of Arbekacin Sulphate Injection versus Vancomycin Injection in Patients Diagnosed with MRSA InfectionAbhay Dube, Ashish Kumar Deb, Chandan Das, et al.
The Journal of the Association of Physicians of India|January 30, 2014
A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary interventionArup Dasbiswas, M Srinivas Rao, Pothineni Ramesh Babu, et al.
Diabetes Research and Clinical Practice|September 19, 2019
Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA studyAjay Kumar Ajmani, Aparna Agrawal, B L N Prasad, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of the Association of Physicians of India|May 1, 2017
Calcium and Calcium SaltsAbhijit Trailokya, Ambrish Srivastava, Milind Bhole, et al.
The Journal of the Association of Physicians of India|February 10, 2025
Real-world Evidence Simplified for CliniciansAbhijit Anil Trailokya, Ambrish Srivastava, Qayum Mukaddam, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Phase IV Studies: What Clinicians Need to Know!Abhijit Trailokya, Ambrish Srivastava, Qayum Mukaddam, et al.
Current Diabetes Reviews|September 16, 2011
Linagliptin: a novel xanthine-based dipeptidyl peptidase-4 inhibitor for treatment of type II diabetes mellitusSomsuvra B Ghatak, Devang S Patel, Neeraj Shanker, et al.
Clinical Drug Investigation|August 12, 2009
Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjectsKumar P Chandra, Ajay Shiwalkar, Jignesh Kotecha, et al.
The Journal of the Association of Physicians of India|July 18, 2019
A Multicentre, Open label, Randomized, Comparative, Parallel Group, Active-controlled, Phase III Clinical Trial to Evaluate Safety and Efficacy of Arbekacin Sulphate Injection versus Vancomycin Injection in Patients Diagnosed with MRSA InfectionAbhay Dube, Ashish Kumar Deb, Chandan Das, et al.
The Journal of the Association of Physicians of India|January 30, 2014
A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary interventionArup Dasbiswas, M Srinivas Rao, Pothineni Ramesh Babu, et al.
Diabetes Research and Clinical Practice|September 19, 2019
Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA studyAjay Kumar Ajmani, Aparna Agrawal, B L N Prasad, et al.
Pageof 1